|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/29/16 Orthofix Medical Inc. 10-K 12/31/15 100:15M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.33M
2: EX-21.1 Subsidiaries List HTML 33K
3: EX-23.1 Consent of Experts or Counsel HTML 34K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 39K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 39K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 35K
13: R1 Document and Entity Information HTML 60K
14: R2 Consolidated Balance Sheets HTML 102K
15: R3 Consolidated Balance Sheets (Parenthetical) HTML 43K
16: R4 Consolidated Statements of Operations and HTML 131K
Comprehensive Loss
17: R5 Consolidated Statements of Changes in HTML 73K
Shareholders' Equity
18: R6 Consolidated Statements of Changes in HTML 36K
Shareholders' Equity (Parenthetical)
19: R7 Consolidated Statements of Cash Flows HTML 135K
20: R8 Description of business HTML 33K
21: R9 Summary of significant accounting policies HTML 171K
22: R10 Inventories HTML 61K
23: R11 Property, plant and equipment HTML 64K
24: R12 Patents and other intangible assets HTML 90K
25: R13 Goodwill HTML 53K
26: R14 Other current liabilities HTML 54K
27: R15 Long-term debt HTML 45K
28: R16 Shareholder's equity HTML 41K
29: R17 Derivative instruments HTML 78K
30: R18 Fair value measurements HTML 194K
31: R19 Commitments HTML 52K
32: R20 Business segment information HTML 262K
33: R21 Income taxes HTML 304K
34: R22 Contingencies HTML 74K
35: R23 Pensions and deferred compensation HTML 40K
36: R24 Share-based compensation plans HTML 311K
37: R25 Earnings per share HTML 37K
38: R26 Quarterly financial data (Unaudited) HTML 286K
39: R27 Summary of significant accounting policies HTML 231K
(Policies)
40: R28 Summary of significant accounting policies HTML 87K
(Tables)
41: R29 Inventories (Tables) HTML 60K
42: R30 Property, plant and equipment (Tables) HTML 59K
43: R31 Patents and other intangible assets (Tables) HTML 90K
44: R32 Goodwill (Tables) HTML 54K
45: R33 Other current liabilities (Tables) HTML 53K
46: R34 Derivative instruments (Tables) HTML 70K
47: R35 Fair value measurements (Tables) HTML 182K
48: R36 Commitments (Tables) HTML 47K
49: R37 Business segment information (Tables) HTML 257K
50: R38 Income taxes (Tables) HTML 306K
51: R39 Share-based compensation plans (Tables) HTML 306K
52: R40 Quarterly financial data (Unaudited) (Tables) HTML 284K
53: R41 Description of Business - Additional Information HTML 32K
(Detail)
54: R42 Summary of Significant Accounting Policies - HTML 103K
Additional Information (Detail)
55: R43 Summary of Significant Accounting Policies - HTML 45K
Schedule of Useful Lives (Detail)
56: R44 Summary of Significant Accounting Policies - HTML 56K
Schedule of Components of Changes in Accumulated
Other Comprehensive Income (Loss) (Detail)
57: R45 Summary of Significant Accounting Policies - HTML 49K
Schedule of Components of Changes in Accumulated
Other Comprehensive Income (Loss) (Parenthetical)
(Detail)
58: R46 Inventories - Schedule of Inventories (Detail) HTML 46K
59: R47 Property, Plant and Equipment - Schedule of HTML 45K
Property,Plant and Equipment (Detail)
60: R48 Property, Plant and Equipment - Additional HTML 38K
Information (Detail)
61: R49 Patents and Other Intangible Assets - Schedule of HTML 44K
Patents and Other Intangibles Assets (Detail)
62: R50 Patents and Other Intangible Assets - Additional HTML 33K
Information (Detail)
63: R51 Patents and Other Intangible Assets - Schedule of HTML 46K
Future Amortization Expense (Detail)
64: R52 Goodwill - Schedule of Net Carrying Amount of HTML 37K
Goodwill (Detail)
65: R53 Other Current Liabilities - Summary of Other HTML 42K
Current Liabilities (Detail)
66: R54 Long-Term Debt - Additional Information (Detail) HTML 106K
67: R55 Stockholders' equity - Additional Information HTML 40K
(Detail)
68: R56 Derivative Instruments - Schedule of Fair Values HTML 40K
of Derivative Instruments (Detail)
69: R57 Derivative Instruments - Schedule of Gain (Loss) HTML 37K
Recognized in Other Comprehensive Income (Loss)
(Detail)
70: R58 Derivative Instruments - Additional Information HTML 55K
(Detail)
71: R59 Fair Value Measurements - Schedule of Financial HTML 65K
Assets and Liabilities Recorded at Fair Value on
Recurring Basis (Detail)
72: R60 Fair Value Measurements - Additional Information HTML 55K
(Detail)
73: R61 Fair Value Measurements - Schedule of HTML 43K
Reconciliation of Debt Securities (Detail)
74: R62 Commitments - Additional Information (Detail) HTML 36K
75: R63 Commitments - Schedule of Future Minimum Lease HTML 44K
Payments Under Operating Leases (Detail)
76: R64 Business Segment Information - Additional HTML 31K
Information (Detail)
77: R65 Business Segment Information - Schedule of Net HTML 52K
Sales by SBU Reporting Segment (Detail)
78: R66 Business Segment Information - Summary of Net HTML 77K
Margin, Defined as Gross Profit Less Sales and
Marketing Expenses from Continuing Operations by
SBU Reporting Segment (Detail)
79: R67 Business Segment Information - Schedule of HTML 45K
Depreciation and Amortization by SBU Reporting
Segment (Detail)
80: R68 Business Segment Information - Summary of Net HTML 53K
Sales by Geographic Destination (Detail)
81: R69 Business Segment Information - Summary of HTML 44K
Property, Plant and Equipment of Reporting
Segments by Geographic Area (Detail)
82: R70 Income Taxes - Schedule of Income (Loss) from HTML 38K
Continuing Operations Before Provision for Income
Taxes (Detail)
83: R71 Income Taxes - Schedule of Provision for (Benefit HTML 53K
from) Income Taxes on Continuing Operations
(Detail)
84: R72 Income Taxes - Schedule of Tax Effects of HTML 68K
Significant Temporary Differences Comprising
Deferred Tax Assets and Liabilities (Detail)
85: R73 Income Taxes - Additional Information (Detail) HTML 45K
86: R74 Income Taxes - Schedule of Effective Income Tax HTML 91K
Rate Reconciliation for Continuing Operations
(Detail)
87: R75 Income Taxes - Schedule of Gross Unrecognized Tax HTML 39K
Benefits (Excluding Interest and Penalties)
(Detail)
88: R76 Contingencies - Additional Information (Detail) HTML 67K
89: R77 Pensions and Deferred Compensation - Additional HTML 68K
Information (Detail)
90: R78 Share-based Compensation plans - Additional HTML 114K
Information (Detail)
91: R79 Share-based Compensation Plans - Schedule of HTML 51K
Share-Based Compensation by Line Item in
Consolidated Statements of Operations (Detail)
92: R80 Share-based Compensation Plans - Schedule of HTML 46K
Share-based Payment Award, Valuation Assumptions
(Detail)
93: R81 Share-based Compensation Plans - Schedule of Stock HTML 68K
Option Activity (Detail)
94: R82 Share-based Compensation Plans - Schedule of Stock HTML 99K
Options Outstanding and Exercisable by Exercise
Price Range (Detail)
95: R83 Share-based Compensation Plans - Schedule of HTML 58K
Changes in Restricted Stock (Detail)
96: R84 Earnings Per Share - Additional Information HTML 48K
(Detail)
97: R85 Quarterly Financial Data - Condensed Consolidated HTML 74K
Statement of Operations (Detail)
99: XML IDEA XML File -- Filing Summary XML 188K
98: EXCEL IDEA Workbook of Financial Reports XLSX 121K
7: EX-101.INS XBRL Instance -- ofix-20151231 XML 4.57M
9: EX-101.CAL XBRL Calculations -- ofix-20151231_cal XML 239K
10: EX-101.DEF XBRL Definitions -- ofix-20151231_def XML 665K
11: EX-101.LAB XBRL Labels -- ofix-20151231_lab XML 1.58M
12: EX-101.PRE XBRL Presentations -- ofix-20151231_pre XML 1.20M
8: EX-101.SCH XBRL Schema -- ofix-20151231 XSD 238K
100: ZIP XBRL Zipped Folder -- 0001564590-16-013722-xbrl Zip 245K
CERTIFICATION
I, Bradley R. Mason, certify that:
|
1. |
I have reviewed this annual report on Form 10-K of Orthofix International N.V.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a. |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b. |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c. |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d. |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has material affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
a. |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
b. |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
Dated: February 29, 2016 |
|
|
|
By: |
|
/s/ BRADLEY R. MASON |
|
|
|
|
|
|
|
Name: Bradley R. Mason |
|
|
|
|
|
|
|
Title: President and Chief Executive Officer, Director |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/29/16 | 8-K | ||
| For Period end: | 12/31/15 | SD | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/09/16 SEC UPLOAD¶ 9/24/17 1:37K Orthofix Medical Inc. 7/13/16 SEC UPLOAD¶ 9/24/17 1:162K Orthofix Medical Inc. |